Mario Raviglione
Mario Raviglione
Professor of Global Health, University of Milan, Italy
Verified email at
TitleCited byYear
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic
EL Corbett, CJ Watt, N Walker, D Maher, BG Williams, MC Raviglione, ...
Archives of internal medicine 163 (9), 1009-1021, 2003
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.
C Dye, S Scheele, P Dolin, V Pathania, MC Raviglione
Jama 282 (7), 677-686, 1999
Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic
MC Raviglione, DE Snider, A Kochi
Jama 273 (3), 220-226, 1995
Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country
C Dye, S Scheele, V Pathania, MC Raviglione
Jama 282 (7), 677-686, 1999
Global surveillance for antituberculosis-drug resistance, 1994–1997
A Pablos-Méndez, MC Raviglione, A Laszlo, N Binkin, HL Rieder, ...
New England Journal of Medicine 338 (23), 1641-1649, 1998
Global tuberculosis incidence and mortality during 1990-2000.
PJ Dolin, MC Raviglione, A Kochi
Bulletin of the World Health Organization 72 (2), 213, 1994
Global trends in resistance to antituberculosis drugs
MA Espinal, A Laszlo, L Simonsen, F Boulahbal, SJ Kim, A Reniero, ...
New England Journal of Medicine 344 (17), 1294-1303, 2001
Zoonotic tuberculosis due to Mycobacterium bovis in developing countries.
O Cosivi, JM Grange, CJ Daborn, MC Raviglione, T Fujikura, D Cousins, ...
Emerging infectious diseases 4 (1), 59, 1998
Drivers of tuberculosis epidemics: the role of risk factors and social determinants
K Lönnroth, E Jaramillo, BG Williams, C Dye, M Raviglione
Social science & medicine 68 (12), 2240-2246, 2009
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries
MA Espinal, SJ Kim, PG Suarez, KM Kam, AG Khomenko, GB Migliori, ...
Jama 283 (19), 2537-2545, 2000
Tuberculosis control and elimination 2010–50: cure, care, and social development
K Lönnroth, KG Castro, JM Chakaya, LS Chauhan, K Floyd, P Glaziou, ...
The lancet 375 (9728), 1814-1829, 2010
Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally
C Dye, CJ Watt, DM Bleed, SM Hosseini, MC Raviglione
Jama 293 (22), 2767-2775, 2005
Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project
DL Cohn, F Bustreo, MC Raviglione
Clinical infectious diseases 24 (Supplement_1), S121-S130, 1997
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D Falzon, E Jaramillo, HJ Schünemann, M Arentz, M Bauer, J Bayona, ...
European Respiratory Journal 38 (3), 516-528, 2011
WHO's new Stop TB Strategy
MC Raviglione, MW Uplekar
The Lancet 367 (9514), 952-955, 2006
Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
A Wright, M Zignol, A Van Deun, D Falzon, SR Gerdes, K Feldman, ...
The Lancet 373 (9678), 1861-1873, 2009
Towards tuberculosis elimination: an action framework for low-incidence countries
K Lönnroth, GB Migliori, I Abubakar, L D'Ambrosio, G De Vries, R Diel, ...
European Respiratory Journal 45 (4), 928-952, 2015
XDR tuberculosis—implications for global public health
MC Raviglione, IM Smith
New England Journal of Medicine 356 (7), 656-659, 2007
HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention
JP Narain, MC Raviglione, A Kochi
Tubercle and lung disease 73 (6), 311-321, 1992
WHO's new end TB strategy
M Uplekar, D Weil, K Lonnroth, E Jaramillo, C Lienhardt, HM Dias, ...
The Lancet 385 (9979), 1799-1801, 2015
The system can't perform the operation now. Try again later.
Articles 1–20